Prime Medicine Stock Forecast

Buy candidate since Jun 17, 2026 Gain 6.65%

The Prime Medicine, Inc. stock price gained 4.33% on the last trading day (Monday, 22nd Jun 2026), rising from $3.23 to $3.37. It has now gained 3 days in a row. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. During the last trading day the stock fluctuated 8.35% from a day low at $3.30 to a day high of $3.57. The price has been going up and down for this period, and there has been a 10.13% gain for the last 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 304 thousand more shares were traded than the day before. In total, 3 million shares were bought and sold for approximately $11.77 million.

The stock lies the upper part of a very wide and falling trend in the short term, and this may normally pose a very good selling opportunity for the short-term trader as reaction back towards the lower part of the trend can be expected. A break up at the top trend line at $3.38 will firstly indicate a slower falling rate, but may be the first sign of a trend shift. Given the current short-term trend, the stock is expected to fall -17.09% during the next 3 months and, with a 90% probability hold a price between $2.03 and $2.80 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

PRME Signals & Forecast

The Prime Medicine, Inc. stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock, but the stock has a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections down, there will be some support from the lines at $3.02 and $3.12. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Wednesday, June 10, 2026, and so far it has risen 24.35%. Further rise is indicated until a new top pivot has been found. Volume is rising along with the price. This is considered to be a good technical signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).

Support, Risk & Stop-loss for Prime Medicine, Inc. stock

Prime Medicine, Inc. finds support from accumulated volume at $3.30 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.275 between high and low, or 8.35%. For the last week, the stock has had daily average volatility of 8.95%.

Our recommended stop-loss: $3.23 (-4.02%) (This stock has high daily movements and this gives high risk. There is a buy signal from a pivot bottom found 7 days ago.)

Trading Expectations (PRME) For The Upcoming Trading Day Of Tuesday 23rd

For the upcoming trading day on Tuesday, 23rd we expect Prime Medicine, Inc. to open at $3.41, and during the day (based on 14 day Average True Range), to move between $3.23 and $3.51, which gives a possible trading interval of +/-$0.271 (+/-8.37%) up or down from last closing price. If Prime Medicine, Inc. takes out the full calculated possible swing range there will be an estimated 8.37% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $3.39 (0.59%) than the support at $3.30 (2.08%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Prime Medicine, Inc. stock A Buy?

Several short-term signals are positive, despite the stock being in a falling trend, we conclude that the current level may hold a buying opportunity as there is a fair chance for stock to perform well in the short-term.

Current score: 2.277 Buy Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on June 23, 2026 - $3.41 ( 1.24%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk